Sugi Predict

Sugi Predict / Targets / SNRPE

SNRPE

Small nuclear ribonucleoprotein E · P62304 · SNRPE on Sugi Atlas →

0 patent compounds predicted against SNRPE, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SNRPE by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Modulation of Steroid Immunosuppression by Alveolar Efferocytosis nanCOMPLETED
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2 nanCOMPLETED
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas nanACTIVE_NOT_RECRUITING
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
Immunophenotyping and Xist Gene in AML nanUNKNOWN
The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction nanCOMPLETED
miRNA as a Growth Plate Marker After GH nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SNRPE binder may also engage these)

ProteinNameSimilarity
A4FUI2 — 1.000 A4FUI2 →
A1XQR9 — 0.998 A1XQR9 →
P62305 — 0.997 P62305 →
P62303 — 0.997 P62303 →
Q7ZUG0 — 0.985 Q7ZUG0 →
Q99MB5 — 0.927 Q99MB5 →
Q8BZL8 — 0.927 Q8BZL8 →
Q3B8H4 — 0.926 Q3B8H4 →
Q8TAP4 — 0.925 Q8TAP4 →
Q503U0 — 0.925 Q503U0 →
Q2KIA3 — 0.924 Q2KIA3 →
Q5RBW7 — 0.924 Q5RBW7 →
P25800 — 0.920 P25800 →
Q8JFQ2 — 0.916 Q8JFQ2 →
Q9YH16 — 0.905 Q9YH16 →
Q5E938 — 0.904 Q5E938 →
P41567 — 0.902 P41567 →
Q5RFF4 — 0.902 Q5RFF4 →
Q8BMJ3 — 0.901 Q8BMJ3 →
P47813 — 0.900 P47813 →
O14602 — 0.899 O14602 →
Q5RA42 — 0.899 Q5RA42 →
P49666 — 0.897 P49666 →
Q924W9 — 0.896 Q924W9 →
G1SHQ2 — 0.896 G1SHQ2 →
Q0P5B3 — 0.895 Q0P5B3 →
RPL21 Large ribosomal subunit protein eL21 0.894 landscape →
O09167 — 0.894 O09167 →
P48024 — 0.894 P48024 →
P51971 — 0.893 P51971 →